Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest lung cancer Stories

2014-03-03 16:25:26

$250,000 to support immuno-oncology learning resources WASHINGTON, March 3, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation is honored to announce a grant of $250,000 from Bristol-Myers Squibb for the development of educational materials on immuno-oncology. Progress in understanding lung cancer and treatment approaches has accelerated dramatically in the past several years after many slow decades. While no immunotherapeutic drugs are currently approved for lung cancer, this new area of...

2014-02-28 23:29:50

Medical Illustrations Improve and Enhance Health Literacy Throughout the World Atlanta, GA (PRWEB) February 28, 2014 Nucleus Medical Media, in an effort to support, improve, and enhance health literacy, has partnered with Dr. Tina St. John, author of “With Every Breath: A Lung Cancer Guidebook” to provide explanatory visuals to lung cancer patients and their families. Dr. St. John, whose husband passed away from lung cancer at a young age, created the Lung Cancer Guidebook to help...

2014-02-27 16:27:45

LCRF Grant Application Deadline June 16, 2014. NEW YORK, Feb. 27, 2014 /PRNewswire-USNewswire/ -- The Lung Cancer Research Foundation announced that it is accepting submissions of grant requests for medical/scientific research projects covering all aspects of lung cancer research. Submissions from investigators at all levels are encouraged including post-doctoral students to world leaders in the field. The maximum grant amount is $50,000 and the deadline for submission is June 16....

2014-02-25 14:34:50

Results Support Need for Combined Testing The findings of a recent study indicate that routine testing with both fluorescent in situ hybridization (FISH) and immunohistochemistry (IHC) may enhance the detection of ALK-positive non-small cell lung cancer (NSCLC). Accurate determination of ALK-positive tumors is necessary to identify patients with advanced NSCLC who are most likely to benefit from targeted therapy with an ALK inhibitor. The discovery of ALK rearrangement in about 1% to 7%...

2014-02-21 23:03:28

BerriHealth continues to support research for the neuroendocrine tumor and carcinoid cancer community. Portland, Oregon (PRWEB) February 21, 2014 BerriHealth, a leader in providing high-quality black raspberry powder for clinical trials and directly to consumers online, has donated a portion of their 2013 sales to New Orleans Louisiana Neuroendocrine Tumor Specialists (NOLANETS), led by Dr. Eugene Woltering. The program is a collaborative effort between the Louisiana State University...

2014-02-19 08:31:13

-- Ramucirumab Improved Survival in Second-Line Study of Patients with Non-Small Cell Lung Cancer -- INDIANAPOLIS, Feb. 19, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the REVEL trial, a global Phase III study of ramucirumab in combination with chemotherapy in patients with second-line non-small cell lung cancer (NSCLC), showed a statistically significant improvement in the primary endpoint of overall survival in the ramucirumab-plus-docetaxel arm...

2014-02-18 23:30:30

Company Will Present its Targeted and Personalized Medicine Approach to Lung Cancer Somerville, MA (PRWEB) February 18, 2014 Andarix Pharmaceuticals, a clinical stage company, announces that it has been selected to present its targeted lung cancer therapy at the 14th Annual Targeted Therapies of the Treatment of Lung Cancer Meeting, also known as the Santa Monica Lung Cancer Meeting. This annual invitation-only meeting gathers the top scientists and clinicians to discuss the latest...

2014-02-14 23:04:29

From Patient to Survivor: Author’s Medical Background and Own Cancer Experience Provides Insight and Inspiration for Rare Type of Cancer San Francisco (PRWEB) February 14, 2014 Over 90% of all carcinoid and neuroendocrine tumors are incorrectly diagnosed and treated for the wrong disease. Maria Gonzalez, MSN, FNP/PA-C, hopes to help reverse this trend by increasing the awareness of this rare and poorly understood type of cancer. Her new book, “But You Look So Good… Stories by...

2014-02-11 23:27:31

The Long Island law firm of Rudolph F. X. Migliore, P.C. announces a high risk alert to people born in the 1940’s and 1950’s. A combination of asbestos exposure and being a part of the baby boomer generation creates a high risk for various lung related illnesses including lung cancer and mesothelioma. (PRWEB) February 11, 2014 One of the most deadly forms of lung cancer is known as mesothelioma and it is no stranger to the post World War II baby boomer generation. There has been an...

Smoking Bad Not Only For Lungs, But Also For Breasts: Study
2014-02-10 13:19:11

[ Watch the Video: Smoking Can Also Give You Breast Cancer ] Brett Smith for redOrbit.com - Your Universe Online Cigarette smoking has frequently been linked to cancers of the respiratory system, but a new study has found that smoking can also greatly increase the risk of a certain breast cancer in women. According to a study recently published in the journal Cancer, young women who smoke a pack per day for a decade or longer have a much greater risk of having the most common kind of...


Latest lung cancer Reference Libraries

Clinical Lung Cancer
2012-05-14 11:09:55

Clinical Lung Cancer is a peer-reviewed medical journal published bimonthly by the CIG Media Group. It was established in 1999. As of May 2012, the editor-in-chief is David R. Gandara. Gandara is a member of the Board of Directors of the International Association for the Study of Lung Cancer and the Addario Foundation. He has also served as a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) and as secretary-treasurer. He is furthermore a member of...

More Articles (1 articles) »